Lucera Erick Insider Trades

Insider Trading History

Track insider trading activity for Lucera Erick. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Dyne Therapeutics
Dyne Therapeutics DYN
Chief Financial Officer
Holding Value $2.51M 123,925 shares
Last Trade
May 13, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$26.6k 1,448 shares
$18.36
$20.26
Dyne Therapeutics
Dyne Therapeutics DYN
Chief Financial Officer
Holding Value $2.54M 125,373 shares
Last Trade
Apr 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$107k 5,727 shares
$18.64
$20.26
Dyne Therapeutics
Dyne Therapeutics DYN
Chief Financial Officer
Holding Value $2.66M 131,100 shares
Last Trade
Feb 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.72M 170,000 shares
$16.00
$20.26
SAB Biotherapeutics
SAB Biotherapeutics SABS
Director
Holding Value $581k 150,000 shares
Last Trade
Dec 16, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$599k 150,000 shares
$3.99
$3.87
SAB Biotherapeutics- Warrants (25/07/2027)
SAB Biotherapeutics- Warrants (25/07/2027) SABSW
Director
Holding Value $1.5k 150,000 shares
Last Trade
Dec 16, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.71k 150,000 shares
$0.02
$0.01
Beyond Air
Beyond Air XAIR
Director
Holding Value $1.73k 3,750 shares
Last Trade
Nov 04, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$22.9k 11,750 shares
$1.95
$0.46
Beyond Air
Beyond Air XAIR
Director
Holding Value $0 0 shares
Last Trade
Nov 04, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$9.3k 5,000 shares
$1.86
$0.46
Dyne Therapeutics
Dyne Therapeutics DYN
Chief Financial Officer
Holding Value $4.35M 214,500 shares
Last Trade
Mar 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.24M 214,500 shares
$10.46
$20.26
Beyond Air
Beyond Air XAIR
Director
Holding Value $34.5k 75,000 shares
Last Trade
Mar 26, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$442k 75,000 shares
$5.89
$0.46
Editas Medicine
Editas Medicine EDIT
Evp, CHIEF FINANCIAL OFFICER
Holding Value $759k 275,100 shares
Last Trade
Mar 08, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$594k 345,100 shares
$1.72
$2.76
Editas Medicine
Editas Medicine EDIT
Evp, CHIEF FINANCIAL OFFICER
Holding Value $311k 112,720 shares
Last Trade
Mar 04, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$7.03k 4,109 shares
$1.71
$2.76
Beyond Air
Beyond Air XAIR
Director
Holding Value $20.7k 45,000 shares
Last Trade
Nov 22, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.73M 160,000 shares
$10.80
$0.46
Beyond Air
Beyond Air XAIR
Director
Holding Value $0 0 shares
Last Trade
Nov 22, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$2.27M 210,000 shares
$10.80
$0.46
Beyond Air
Beyond Air XAIR
Director
Holding Value $20.1k 43,608 shares
Last Trade
Aug 14, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$314k 39,266 shares
$8.00
$0.46
SAB Biotherapeutics- Warrants (25/07/2027)
SAB Biotherapeutics- Warrants (25/07/2027) SABSW
Director
Holding Value $200 20,000 shares
Last Trade
Jul 15, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$766 20,000 shares
$0.04
$0.01
SAB Biotherapeutics
SAB Biotherapeutics SABS
Director
Holding Value $77.4k 20,000 shares
Last Trade
Jul 15, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$58k 20,000 shares
$2.90
$3.87
Editas Medicine
Editas Medicine EDIT
Evp, CHIEF FINANCIAL OFFICER
Holding Value $322k 116,829 shares
Last Trade
May 20, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$125k 22,337 shares
$5.61
$2.76
Beyond Air
Beyond Air XAIR
Director
Holding Value $20.7k 45,000 shares
Last Trade
Mar 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.39M 45,000 shares
$30.80
$0.46
Editas Medicine
Editas Medicine EDIT
Evp, CHIEF FINANCIAL OFFICER
Holding Value $384k 139,166 shares
Last Trade
Mar 02, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.12M 106,000 shares
$10.53
$2.76
Bone Biologics - Warrants (13/10/2026)
Bone Biologics - Warrants (13/10/2026) BBLGW
Director
Holding Value $1.37M 85,763 shares
Last Trade
Sep 18, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.62M 85,763 shares
$53.82
$15.99

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up